Tvardi Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Tvardi Therapeutics stock have an average target of 51.67, with a low estimate of 15 and a high estimate of 78. The average target predicts an increase of 1,185.32% from the current stock price of 4.02.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$51.67	$61	$78
Change	+273.13%	+1185.3%	+1417.4%	+1840.3%

* Price targets were last updated on Oct 13, 2025.

Analyst Ratings

The average analyst rating for Tvardi Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	2	2	2	2	2
Buy	4	4	4	4	4	4
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Deschner Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Oct 14, 2025
Julian Harrison BTIG	BTIG	Strong Buy Maintains $55 → $15	Strong Buy	Maintains	$55 → $15	+273.13%	Oct 13, 2025
Etzer Darout Barclays	Barclays	Buy Initiates $61	Buy	Initiates	$61	+1,417.41%	Oct 13, 2025
Ryan Deschner Raymond James	Raymond James	Buy Initiates $62	Buy	Initiates	$62	+1,442.29%	Jul 14, 2025
Steve Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $52	Buy	Initiates	$52	+1,193.53%	Jul 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

331.50K

Revenue Next Year

n/a

from 331.50K

EPS This Year

-2.50

from -4.59

EPS Next Year

-2.10

from -2.50

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	331.50K	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.22	-2.72	-4.59	-2.50	-2.10	-3.62	-3.04
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	10	10	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	2.7M	n/a
Avg	331,500	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-1.41	-1.47
Avg	-2.50	-2.10
Low	-4.44	-3.10

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.